These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26485389)

  • 1. Structure Elucidation of Coxsackievirus A16 in Complex with GPP3 Informs a Systematic Review of Highly Potent Capsid Binders to Enteroviruses.
    De Colibus L; Wang X; Tijsma A; Neyts J; Spyrou JA; Ren J; Grimes JM; Puerstinger G; Leyssen P; Fry EE; Rao Z; Stuart DI
    PLoS Pathog; 2015 Oct; 11(10):e1005165. PubMed ID: 26485389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
    Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
    Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
    Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
    J Virol; 2021 May; 95(12):. PubMed ID: 33789997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
    Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
    J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding.
    Lin CJ; Liu CH; Wang JY; Lin CC; Li YF; Richardson CD; Lin LT
    Emerg Microbes Infect; 2018 Sep; 7(1):162. PubMed ID: 30254193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human enterovirus 71 uncoating captured at atomic resolution.
    Lyu K; Ding J; Han JF; Zhang Y; Wu XY; He YL; Qin CF; Chen R
    J Virol; 2014 Mar; 88(6):3114-26. PubMed ID: 24352461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of human enterovirus 71.
    Plevka P; Perera R; Cardosa J; Kuhn RJ; Rossmann MG
    Science; 2012 Jun; 336(6086):1274. PubMed ID: 22383808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
    Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
    Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
    Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
    Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.
    Zhang M; Wang Y; He W; Sun Y; Guo Y; Zhong W; Gao Q; Liao M; Wang X; Cai Y; Guo Y; Rao Z
    J Med Chem; 2020 Feb; 63(3):1233-1244. PubMed ID: 31939669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel substituted heteroaromatic piperazine and piperidine derivatives as inhibitors of human enterovirus 71 and coxsackievirus a16.
    Zhang X; Wang H; Li Y; Cao R; Zhong W; Zheng Z; Wang G; Xiao J; Li S
    Molecules; 2013 Apr; 18(5):5059-71. PubMed ID: 23629759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
    Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
    Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
    He SJ; Han JF; Ding XX; Wang YD; Qin CF
    Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synonymous codon usage analysis of hand, foot and mouth disease viruses: A comparative study on coxsackievirus A6, A10, A16, and enterovirus 71 from 2008 to 2015.
    Su W; Li X; Chen M; Dai W; Sun S; Wang S; Sheng X; Sun S; Gao C; Hou A; Zhou Y; Sun B; Gao F; Xiao J; Zhang Z; Jiang C
    Infect Genet Evol; 2017 Sep; 53():212-217. PubMed ID: 28602802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of antibody neutralization of coxsackievirus A16.
    Zhang C; Liu C; Shi J; Wang Y; Xu C; Ye X; Liu Q; Li X; Qiao W; Yin Y; Cong Y; Huang Z
    Nat Commun; 2022 Dec; 13(1):7854. PubMed ID: 36543790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional motions and related key residues behind the uncoating of coxsackievirus A16.
    He XL; Du LF; Zhang J; Liang Y; Wu YD; Su JG; Li QM
    Proteins; 2021 Oct; 89(10):1365-1375. PubMed ID: 34085313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.